Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 47 Squamous Cell Carcinoma of Head and Neck 24 Head and Neck Neoplasms 21 Lung Neoplasms 19 Neoplasms 18 Stomach Neoplasms 15 Urinary Bladder Neoplasms 14 Uterine Cervical Neoplasms 11 Small Cell Lung Carcinoma 11 Ovarian Neoplasms 11 Esophageal Neoplasms 11 Colorectal Neoplasms 11 Pancreatic Neoplasms 10 Biliary Tract Neoplasms 10 Carcinoma, Transitional Cell 9 Triple Negative Breast Neoplasms 8 Neoplasm Metastasis 8 Breast Neoplasms 8 Oropharyngeal Neoplasms 7 Mesothelioma, Malignant 7 Melanoma 7 Cholangiocarcinoma 7 Carcinoma, Squamous Cell 6 Recurrence 5 Nasopharyngeal Carcinoma 5 Mesothelioma 5 Esophageal Squamous Cell Carcinoma 5 Carcinoma 5 Nasopharyngeal Neoplasms 4 Mouth Neoplasms 4

Interventions

carfilzomib 2 Dexamethasone 2 Cyclophosphamide 2 tivozanib 1 tislelizumab 1 pembrolizumab 1 neratinib 1 Nivolumab 1 Interleukin-15 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Cisplatin 1 Capecitabine 1 Calcium Dobesilate 1 Bevacizumab 1 Albumin-Bound Paclitaxel 1 3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Disease × Cisplatin × Clear all

NCT01730222 2017-09-01

PACT-19

IRCCS San Raffaele

Phase 1/2 Completed

Gastrointestinal

Disease, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡